Mercer Global Advisors
KYMR icon

Mercer Global Advisors’s Kymera Therapeutics KYMR Stock Holding History

Mercer Global Advisors’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Buy
+916
New +$78.7K ﹤0.01% 3804

Other funds holding KYMR

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mercer Global Advisors's KYMR Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Kymera Therapeutics (KYMR) in Q2 2026: 916 shares worth $105K. The stake represents ﹤0.01% of the portfolio and ranks #3804 among its holdings.

255 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Mercer Global Advisors held 916 shares of Kymera Therapeutics worth $105K as of Q2 2026.
  • Kymera Therapeutics was a new Mercer Global Advisors position in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3804 holding.
  • 255 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.